The global pharmaceuticals market is witnessing relentless growth due to a worldwide rise in life expectancy coupled with the increasing incidence of chronic and infectious diseases. Consequently, the mounting demand for innovative drugs has triggered a significant increase in R&D investments across the sector.

Emerging markets are playing a major role in Life Sciences. As a result, companies are significantly expanding investment in emerging markets across a wide range of activities. Though the US currently holds around 45% of the global market share, economies like China and India are expected to show double-digit growth over the coming years.

Demand for medical scientists, biochemists and biophysicists will also rise. A growing need for innovative medical technologies and an aging population will drive demand for better medical devices and equipment. An era of tightening budgets and reduced government spending brings to the fore expertise in market access and pricing and reimbursement strategy.

Undeniably, the Life Sciences sector is undergoing a profound change. As companies transition towards a bottom line management focus, savings from consulting, outsourcing and outside technical services become ever more important to the Boards and executives leading these global businesses.

Borderless consultants are well acquainted with the demands of the Life Sciences sector - from pharma, medical devices and disposables to diagnostics and biotechnology. We can help you attract and retain international executives to meet these challenges.

Contact us to find out how.